Clinical Trial

Retinal Blood Flow and Autoregulation

Name: Retinal Blood Flow and Autoregulation — clinical trial record (NCT05344274)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this study is to establish autoregulation of retinal blood flow in arterioles and capillaries as a biomarker for early primary open angle glaucoma.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2022-04-18; most recent amendment 2025-11-24.

Status change: Not Yet Recruiting → Recruiting 2022-07-19

Trial Details

NCT Number	NCT05344274
Lead Sponsor	University of Maryland, Baltimore
Conditions	Glaucoma
Enrollment	90 participants
Start Date	2022-05-23
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2025-12-02